Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 337

1.

Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

Aarsland D, Litvan I, Larsen JP.

J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):42-9.

PMID:
11207328
[PubMed - indexed for MEDLINE]
2.

Apathy is not depression.

Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I.

J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):314-9.

PMID:
9706539
[PubMed - indexed for MEDLINE]
3.

"Applause sign" helps to discriminate PSP from FTD and PD.

Dubois B, Slachevsky A, Pillon B, Beato R, Villalponda JM, Litvan I.

Neurology. 2005 Jun 28;64(12):2132-3.

PMID:
15985587
[PubMed - indexed for MEDLINE]
4.

Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.

Defebvre L, Lecouffe P, Destée A, Houdart P, Steinling M.

Acta Neurol Scand. 1995 Sep;92(3):235-41.

PMID:
7484078
[PubMed - indexed for MEDLINE]
5.

Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Asahina M, Suhara T, Shinotoh H, Inoue O, Suzuki K, Hattori T.

J Neurol Neurosurg Psychiatry. 1998 Aug;65(2):155-63.

PMID:
9703164
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Neuropsychological deficits in Parkinson's disease patients with visual hallucinations.

Ramírez-Ruiz B, Junqué C, Martí MJ, Valldeoriola F, Tolosa E.

Mov Disord. 2006 Sep;21(9):1483-7.

PMID:
16705661
[PubMed - indexed for MEDLINE]
7.

Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?

Lannuzel A, Höglinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, Poullain P, Oertel WH, Hirsch EC, Dubois B, Ruberg M.

Brain. 2007 Mar;130(Pt 3):816-27. Epub 2007 Feb 15.

PMID:
17303592
[PubMed - indexed for MEDLINE]
Free Article
8.

Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.

Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD.

Brain. 1997 Jan;120 ( Pt 1):75-90.

PMID:
9055799
[PubMed - indexed for MEDLINE]
Free Article
9.

Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.

Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D.

Neurology. 1993 May;43(5):962-5.

PMID:
8492953
[PubMed - indexed for MEDLINE]
10.

Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.

Soliveri P, Monza D, Paridi D, Carella F, Genitrini S, Testa D, Girotti F.

J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):313-8.

PMID:
10945805
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.

Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D'Olhaberriague L.

Brain. 1997 Jan;120 ( Pt 1):65-74.

PMID:
9055798
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.

Sixel-Döring F, Schweitzer M, Mollenhauer B, Trenkwalder C.

Sleep Med. 2009 Apr;10(4):407-15. doi: 10.1016/j.sleep.2008.05.004. Epub 2008 Oct 21.

PMID:
18945638
[PubMed - indexed for MEDLINE]
14.

Neuropsychiatric aspects of progressive supranuclear palsy.

Litvan I, Mega MS, Cummings JL, Fairbanks L.

Neurology. 1996 Nov;47(5):1184-9.

PMID:
8909427
[PubMed - indexed for MEDLINE]
15.

Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.

Krishnan S, Mathuranath PS, Sarma S, Kishore A.

Neurol India. 2006 Sep;54(3):268-72.

PMID:
16936386
[PubMed - indexed for MEDLINE]
Free Article
16.

Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.

Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A.

Brain. 2006 Oct;129(Pt 10):2679-87. Epub 2006 Jun 30.

PMID:
16815875
[PubMed - indexed for MEDLINE]
Free Article
17.

Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases.

Pillon B, Deweer B, Michon A, Malapani C, Agid Y, Dubois B.

Neurology. 1994 Jul;44(7):1264-70.

PMID:
8035927
[PubMed - indexed for MEDLINE]
18.

Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.

Borroni B, Alberici A, Agosti C, Cosseddu M, Padovani A.

Int Psychogeriatr. 2009 Jun;21(3):463-8. doi: 10.1017/S1041610209008862. Epub 2009 Mar 27.

PMID:
19323870
[PubMed - indexed for MEDLINE]
19.

Concentration of neural thread protein in cerebrospinal fluid from progressive supranuclear palsy and Parkinson's disease.

Yamada T, Chong JK, Asahina M, Koguchi Y, Hirayama K.

Jpn J Psychiatry Neurol. 1993 Sep;47(3):631-5.

PMID:
8301879
[PubMed - indexed for MEDLINE]
20.

Neuropsychiatric features of corticobasal degeneration.

Litvan I, Cummings JL, Mega M.

J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):717-21.

PMID:
9810944
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk